
LPTX
Healthcare · Biotechnology · $116.1M market cap
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2025
EPS trend, 90 days to now · +36.5% over 90 days · 30-day revisions 0 up, 1 down
Beat estimates in 3 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Aug 14, 2025 | Time not confirmed | -0.42 | -0.40 | +4.8% |
| May 12, 2025 | Before the open | -0.38 | -0.37 | +2.6% |
| Mar 17, 2025 | Before the open | -0.36 | -0.37 | -2.8% |
| Nov 11, 2024 | Before the open | -0.48 | -0.44 | +8.3% |
| Aug 12, 2024 | Before the open | -0.43 | -0.52 | -20.9% |
| May 13, 2024 | Before the open | -0.58 | 0.51 | +187.9% |
| Mar 18, 2024 | Before the open | -0.55 | -0.46 | +16.4% |
| Nov 13, 2023 | Before the open | -0.58 | -0.51 | +12.1% |
| Aug 14, 2023 | Before the open | -0.90 | -0.91 | -1.1% |
| May 15, 2023 | Before the open | -0.10 | -0.32 | -220.0% |
| Mar 24, 2023 | Before the open | -0.11 | -0.10 | +9.1% |
| Nov 14, 2022 | Before the open | -0.12 | -0.13 | -8.3% |
| Aug 12, 2022 | Before the open | -0.10 |
Cypherpunk Technologies Inc., a biopharmaceutical company, acquires and develops antibody therapies for the treatment of cancer. Its lead clinical stage drug candidate includes DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in various ongoing clinical trials for treating esophagogastric and gynecologic cancers, and colorectal cancer. The company also develops FL-501, a monoclonal…
| -0.15 |
| -50.0% |
| May 13, 2022 | Before the open | -0.10 | -0.09 | +10.0% |
| Mar 11, 2022 | Before the open | -0.11 | -0.10 | +9.1% |
| Nov 12, 2021 | Before the open | -0.11 | -0.14 | -27.3% |
| Aug 13, 2021 | Before the open | -0.12 | -0.12 | 0.0% |
| May 14, 2021 | Before the open | -0.11 | -0.12 | -9.1% |
| Mar 12, 2021 | Before the open | -0.09 | -0.09 | 0.0% |
| Nov 12, 2020 | Before the open | -0.13 | -0.09 | +30.8% |
| Aug 13, 2020 | Before the open | -0.18 | -0.12 | +33.3% |
| May 14, 2020 | Before the open | -0.24 | -0.25 | -4.2% |
| Mar 16, 2020 | Before the open | -0.32 | -0.33 | -3.1% |
| Nov 14, 2019 | Before the open | -0.33 | -0.33 | 0.0% |
| Aug 9, 2019 | Before the open | -0.42 | -0.37 | +11.9% |
| May 15, 2019 | Before the open | -0.41 | -0.47 | -14.6% |
| Dec 31, 2018 | Time not confirmed | -0.57 | 0.12 | +121.1% |
| Nov 9, 2018 | Before the open | -0.44 | -0.45 | -2.3% |
| Aug 8, 2018 | Before the open | -0.49 | -0.50 | -2.0% |
| May 11, 2018 | Before the open | -0.61 | -0.46 | +24.6% |
| Feb 23, 2018 | Before the open | -0.82 | -0.65 | +20.7% |